Lataa...
Proteomic cancer biomarkers from discovery to approval: it’s worth the effort
The current landscape of cancer biomarkers is changing rapidly, with new and exciting developments. With the advances of proteomic technologies, many potential cancer biomarkers have been discovered. However, the number of new cancer biomarkers cleared or approved by the US FDA is rather limited. Al...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4079106/ https://ncbi.nlm.nih.gov/pubmed/24646122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14789450.2014.897614 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|